Update
What we know: Biotrial clinical trial tragedy
On Friday, the French Minister of Health addressed the public pledging to provide answers after one man was declared clinically dead as the result of a clinical trial gone wrong.
Update
On Friday, the French Minister of Health addressed the public pledging to provide answers after one man was declared clinically dead as the result of a clinical trial gone wrong.
UK-based biotech Centauri Therapeutics has acquired a “programmable immunity” aptamer technology from Altermune Technologies.
Researchers have found a way to illuminate and track a common cancer drug, a method which shows promise in advancing personalized medicine.
A study halted in France after one volunteer died and others were injured differs markedly from the disastrous “elephant man” trial that hospitalized six in the UK in 2006 according to the MHRA.